Partial reduction of BACE1 decreased the levels of APP-βCTF in the brain, instead of Aβ or APP, preventing neuronal endosomal pathology, loss of neurons, and development of the AD-related phenotype in Ts2.BACE1+/− mice [18]. The gene discussed is BACE1; the disease is Alzheimer disease.